Description:

This advanced course provides updates on the classification of hematolymphoid tumors according to the 5th edition of the WHO guidelines, focusing on Histiocytic/Dendritic cell neoplasms. Part 2 delves deeper into the intricacies of these rare neoplasms, covering diagnostic criteria, clinical correlations, and recent advancements in treatment options.

Key Highlights:

• In-depth analysis of Histiocytic/Dendritic cell neoplasms
• Latest updates based on WHO 5th edition guidelines
• Clinical correlations and treatment strategies

What you will learn:

 

Histiocyte/macrophage neoplasms

• Histiocytic neoplasms
• Juvenile xanthogranuloma
• Erdheim-Chester disease
• Rosai-Dorfman Disease
• ALK-positive histiocytosis
• Histiocytic sarcoma
• Comprehensive Understanding
  Gain a comprehensive understanding of the diagnostic criteria and classification of Histiocytic/Dendritic cell neoplasms as per the latest WHO guidelines.
• Clinical Relevance
  Learn about the clinical correlations and implications for patient management in the context of Histiocytic/Dendritic cell neoplasms.
• Cutting-edge Research
  Stay updated with the latest research and treatment modalities for rare hematolymphoid tumors, particularly focusing on Histiocytic/Dendritic cell neoplasms.